Company Information

Dr Philip Burke BSc, PhD

Phil is a co-founder of Morvus and was a co-founder of Enact Pharma plc holding the position of acting Chief Scientific Officer when it was purchased by Protherics Plc. He was previously Director of Chemistry of Enzacta Group Plc and is a medicinal chemist by training with a wide experience in the therapy of a number of diseases. Prior to his commercial career he led a research team at Imperial College developing novel anti-cancer agents. He has a BSc in chemistry from Manchester University and a PhD from London University.

Back

Board of Directors | Senior Management